Status:
TERMINATED
Cardiovascular Magnetic Resonance for the Occluded Infarct-Related Artery Treatment
Lead Sponsor:
National Institute of Cardiology, Warsaw, Poland
Conditions:
Cardiovascular Diseases
Heart Diseases
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether opening an occluded infarcted artery 3-28 days after an acute myocardial infarction in high-risk asymptomatic patients with preserved infarct zone via...
Detailed Description
Rapid restoration of blood flow in the infarct-related artery (IRA), one of the cornerstones of contemporary treatment of acute myocardial infarction (MI) prevents myocardial necrosis and its conseque...
Eligibility Criteria
Inclusion
- Enrollment 3-28 days after an acute myocardial infarction.
- Infarct related artery occlusion (TIMI 0 or 1).
- High risk: left ventricular ejection fraction (LVEF)\<50% or LVEF\>50% and proximal coronary occlusion.
- Preserved infarct zone viability (necrosis transmurality \<50% in at least 4 segments out of 17 according to AHA classification).
Exclusion
- Unstable clinical condition
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT00968383
Start Date
September 1 2009
End Date
December 1 2012
Last Update
May 14 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Cardiology
Warsaw, Poland, 04-628